(MENAFN- iCrowdNewsWire)
The global isothermal nucleic acid amplification technology market size reached US$ 2.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2027, exhibiting at a CAGR of 12.7 % during 2022-2027, according to a new report by IMARC Group.
Isothermal nucleic acid amplification technology (INAAT) is primarily deployed in the field of molecular biology for identifying and analyzing nucleic acids. It is majorly used for DNA , RNA, cell protein, ions, molecules, etc. INAAT offers a rapid, sensitive, and accurate diagnosis of genetic as well as infectious ailments. It provides amplicons for producing various nucleic acids that are predominantly utilized in biosensing, bioimaging, and biomedicines. Furthermore, INAAT is also used for detecting several diseases, such as influenza, HIV, tuberculosis, chlamydia, and gonorrhea (CT/NG), Hepatitis A and B, etc.
COVID-19 Impact Analysis
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF Sample for more detailed market insights:
INAAT Market Trends:
The widespread of COVID-19 has led to the rapid shift from specialized laboratory equipment towards INAAT for coronavirus detection. Additionally, the high prevalence of several chronic diseases has augmented the demand for effective diagnosis and treatment procedures, which is propelling the market growth. The increasing popularity of INAAT in identifying genetically modified organisms (GMOs) is also catalyzing the market. Several technological advancements in the sector have led to the development of Recombinase Polymerase Amplification (RPA), Single Primer Isothermal Amplification (SPIA), and Strand Displacement Amplification (SDA). The rising investments in various R&D activities are anticipated to bolster the market for INAAT in the coming years.
For more information about this report visit:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of the key players being Abbott Laboratories (NYSE: ABT), BIOMERIEUX (BIM.PA), BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, Ustar Biotechnologies Ltd., etc.
Global Isothermal Nucleic Acid Amplification Technology/INAAT Market 2021-2026 Analysis and Segmentation:
Breakup by Product:
Breakup by Technology:
- Helicase-Dependent Amplification (HDA)
- Nicking Enzyme Amplification Reaction (NEAR)
- Loop-Mediated Isothermal Amplification (LAMP)
- Strand Displacement Amplification (SDA)
- Nucleic Acid Sequence-Based Amplification (NASBA)
- Transcription Mediated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Others
Breakup by Application:
- Infectious Disease Diagnosis
- Hepatitis
- CT/NG
- HIV
- Influenza
- Others
- Blood Screening
- Others
Breakup by End-User:
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Others
Breakup by Region:
- North America
- Asia PacificEurope
- Latin America
- Middle East and Africa
Browse more Healthcare industry reports:
Body Contouring Market Report:
Bariatric Surgery Devices Market Report:
Metabolomics Market Research Report:
Nicotine Gum Market Report:
Biopsy Devices Market Research Report:
Human Insulin Market Research Report:
Medical Billing Outsourcing Market Report:
Respiratory Diagnostics Market Research Report :
Cannula Market Report:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
MENAFN14012022003318003403ID1103541654
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.